# LAMBDA 002 (Lung Registry) Study

> **NCT05170425** · — · ACTIVE_NOT_RECRUITING · sponsor: **Natera, Inc.** · enrollment: 154 (actual)

## Conditions studied

- Lung Transplant Rejection

## Interventions

- **DEVICE:** Prospera

## Key facts

- **NCT ID:** NCT05170425
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-04
- **Primary completion:** 2026-08
- **Final completion:** 2027-05
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170425, "LAMBDA 002 (Lung Registry) Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05170425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*